Mr. Hall is a serial entrepreneur, and graduate of University of California Santa Cruz. Prior to Prosel Biosciences, Mr. Hall co-founded Immusoft Corporation, a gene-modified cell therapy company pioneering the use of human B cells as a platform to enable cell-based drug delivery
Microalgae have a rich diversity of genetic and metabolic pathways for optimized strain development. Prosel is developing two distinct platform technologies to enable rapid product development from...